Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals (NQ: RIGL )

1.880 +0.080 (+4.44%)
Streaming Delayed Price Updated: 3:09 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,378,165
Open 1.820
Bid (Size) 1.870 (136)
Ask (Size) 1.880 (56)
Prev. Close 1.800
Today's Range 1.780 - 1.880
52wk Range 1.790 - 4.620
Shares Outstanding 172,052,224
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF) 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga

Performance

YTD
-31.39%
-31.39%
1 Month
-25.40%
-25.40%
3 Month
-23.89%
-23.89%
6 Month
-32.13%
-32.13%
1 Year
-49.05%
-49.05%

More News

Read More
Recap: Rigel Pharmaceuticals Q1 Earnings
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Via Benzinga
Earnings Scheduled For March 1, 2022
Via Benzinga
Earnings Scheduled For November 2, 2021
Via Benzinga
Earnings Scheduled For May 3, 2022
Via Benzinga
Preview: Rigel Pharmaceuticals's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022
Via Benzinga
Looking Into Rigel Pharmaceuticals's Return On Capital Employed
Via Benzinga
Recap: Rigel Pharmaceuticals Q4 Earnings
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Rigel Pharmaceuticals's Earnings Outlook
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Via Benzinga
Topics Retirement
Exposures Pension
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Investor Alert: Investigation over Potential Wrongdoing
Via SBWire
Exposures COVID-19
NASDAQ:RIGL Shareholder Notice: Investigation over Possible Securities Laws Violations by Rigel Pharmaceuticals, Inc.
Via SBWire
Exposures COVID-19
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
Via The Motley Fool
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Rigel Stock Falls After Update From COVID-19 Program
Via Benzinga
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.